{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000340.3:c.137A>G",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "A",
            "alt": "G",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "G",
            "position": "46"
          },
          "Description in input context": "E46K mutation in alpha-synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Dementia with Lewy Bodies",
    "MONDO": "MONDO:0005335"
  },
  "Experiment Method": [
    {
      "Assay Method": "Phospholipid Binding Assay and Filament Assembly Analysis",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "Alpha-synuclein variants (E46K, wild-type)",
        "Description": "Recombinant alpha-synuclein variants were expressed and purified for analysis."
      },
      "Readout type": "Mixed (Quantitative and Qualitative)",
      "Readout description": [
        {
          "Variant": "NM_000340.3:c.137A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased phospholipid binding and filament assembly rates",
          "Result Description": "The E46K variant showed significantly higher phospholipid binding affinity and accelerated filament formation compared to wild-type, with a twisted morphology observed under microscopy."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type alpha-synuclein was used as a positive control for binding and filament formation."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "No explicit negative control mentioned."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Standard threshold for phospholipid binding and filament assembly rates based on wild-type controls.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly higher binding affinity (e.g., >20% increase) or altered filament morphology compared to wild-type.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}